CrossLife Technologies Overview

  • Founded
  • 2010
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $225K
Latest Deal Amount
  • Investors
  • 4

CrossLife Technologies General Information


Developer of molecular diagnostics technologies designed to detect infectious and non-communicable diseases. The company's molecular diagnostics technologies are based on nucleic acid and DNA and it develops technologies into pathogen detection tests for many infectious diseases including HIV, malaria, chikungunya and flu, enabling doctors to detect infectious pathogens directly from diverse sample types without sample preparation, polymerase chain reaction or instrumentation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Primary Office
  • 3129 Tiger Run Court
  • Suite 111
  • Carlsbad, CA 92010
  • United States
+1 (760) 000-0000

CrossLife Technologies Timeline

Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CrossLife Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 01-Jan-2018 $225K Completed Startup
3. Grant 01-Jan-2017 00000 Completed Startup
2. Grant 10-Mar-2016 $2.43M Completed Startup
1. Accelerator/Incubator Completed Startup
To view CrossLife Technologies’s complete valuation and funding history, request access »

CrossLife Technologies Executive Team (1)

Name Title Board Seat Contact Info
Hyundae Cho Ph.D Founder, President & Chief Executive Officer
To view CrossLife Technologies’s complete executive team members history, request access »

CrossLife Technologies Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Bio, Tech and Beyond Accelerator/Incubator 000 0000 000000 0
To view CrossLife Technologies’s complete investors history, request access »